JP2014527821A5 - - Google Patents

Download PDF

Info

Publication number
JP2014527821A5
JP2014527821A5 JP2014531048A JP2014531048A JP2014527821A5 JP 2014527821 A5 JP2014527821 A5 JP 2014527821A5 JP 2014531048 A JP2014531048 A JP 2014531048A JP 2014531048 A JP2014531048 A JP 2014531048A JP 2014527821 A5 JP2014527821 A5 JP 2014527821A5
Authority
JP
Japan
Prior art keywords
derived
adipose tissue
cells
use according
passaged
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014531048A
Other languages
English (en)
Japanese (ja)
Other versions
JP6162123B2 (ja
JP2014527821A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/AU2012/001140 external-priority patent/WO2013040649A1/en
Publication of JP2014527821A publication Critical patent/JP2014527821A/ja
Publication of JP2014527821A5 publication Critical patent/JP2014527821A5/ja
Application granted granted Critical
Publication of JP6162123B2 publication Critical patent/JP6162123B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014531048A 2011-09-23 2012-09-21 脂肪細胞および細胞分泌物を使用する治療 Active JP6162123B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
AU2011903938 2011-09-23
AU2011903938A AU2011903938A0 (en) 2011-09-23 Therapeutic methods and compositions
AU2012901350A AU2012901350A0 (en) 2012-04-04 Therapeutic methods and compositions
AU2012901350 2012-04-04
AU2012903646 2012-08-23
AU2012903646A AU2012903646A0 (en) 2012-08-23 Therapeutic methods and compositions
PCT/AU2012/001140 WO2013040649A1 (en) 2011-09-23 2012-09-21 Therapeutics using adipose cells and cell secretions

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2017116648A Division JP6839038B2 (ja) 2011-09-23 2017-06-14 脂肪細胞および細胞分泌物を使用する治療

Publications (3)

Publication Number Publication Date
JP2014527821A JP2014527821A (ja) 2014-10-23
JP2014527821A5 true JP2014527821A5 (https=) 2015-11-12
JP6162123B2 JP6162123B2 (ja) 2017-07-12

Family

ID=47913679

Family Applications (5)

Application Number Title Priority Date Filing Date
JP2014531048A Active JP6162123B2 (ja) 2011-09-23 2012-09-21 脂肪細胞および細胞分泌物を使用する治療
JP2017116648A Expired - Fee Related JP6839038B2 (ja) 2011-09-23 2017-06-14 脂肪細胞および細胞分泌物を使用する治療
JP2019090715A Expired - Fee Related JP6912512B2 (ja) 2011-09-23 2019-05-13 脂肪細胞および細胞分泌物を使用する治療
JP2021111459A Expired - Fee Related JP7022863B2 (ja) 2011-09-23 2021-07-05 脂肪細胞および細胞分泌物を使用する治療
JP2021195358A Pending JP2022033865A (ja) 2011-09-23 2021-12-01 脂肪細胞および細胞分泌物を使用する治療

Family Applications After (4)

Application Number Title Priority Date Filing Date
JP2017116648A Expired - Fee Related JP6839038B2 (ja) 2011-09-23 2017-06-14 脂肪細胞および細胞分泌物を使用する治療
JP2019090715A Expired - Fee Related JP6912512B2 (ja) 2011-09-23 2019-05-13 脂肪細胞および細胞分泌物を使用する治療
JP2021111459A Expired - Fee Related JP7022863B2 (ja) 2011-09-23 2021-07-05 脂肪細胞および細胞分泌物を使用する治療
JP2021195358A Pending JP2022033865A (ja) 2011-09-23 2021-12-01 脂肪細胞および細胞分泌物を使用する治療

Country Status (9)

Country Link
US (3) US10111909B2 (https=)
EP (3) EP2744892B1 (https=)
JP (5) JP6162123B2 (https=)
AU (1) AU2012313352B2 (https=)
CA (1) CA2885487C (https=)
DK (2) DK3546569T3 (https=)
ES (2) ES2880084T3 (https=)
SG (2) SG2014013676A (https=)
WO (1) WO2013040649A1 (https=)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9192695B2 (en) 2008-11-20 2015-11-24 Allosource Allografts combined with tissue derived stem cells for bone healing
JP2023002772A (ja) * 2011-09-23 2023-01-10 レジニアス リミテッド 脂肪細胞および細胞分泌物を使用する治療
EP2744892B1 (en) * 2011-09-23 2019-03-20 Cell Ideas Pty Ltd. Therapeutics using adipose cells and cell secretions
AU2013204930C1 (en) * 2012-09-26 2015-01-22 Cell Ideas Pty Ltd Therapeutics using multiple injections of cells
EP2919794B1 (en) 2012-11-15 2021-01-20 AlloSource Minced cartilage systems and methods
US10357538B2 (en) 2012-12-24 2019-07-23 Northern Sydney Local Health District Vaccines for the treatment of cancer and compositions for enhancing vaccine efficacy
CA2894750C (en) 2013-02-22 2021-12-14 Allosource Cartilage mosaic compositions and methods
AU2014236705B2 (en) 2013-03-15 2018-04-12 Allosource Perforated osteochondral allograft compositions
CA2899713C (en) 2013-03-15 2022-07-19 Allosource Cell repopulated collagen matrix for soft tissue repair and regeneration
US10206954B2 (en) * 2013-06-19 2019-02-19 Spinalcyte, Llc Adipose cells for chondrocyte applications
EP3052943B1 (en) 2013-10-04 2019-11-20 Cell Ideas Pty Ltd. Biomarkers for cell therapy
WO2016094932A1 (en) 2014-12-19 2016-06-23 Cell Ideas Pty Ltd Improved cell therapies
CN108348555B (zh) 2015-09-08 2022-07-08 赛尔爱迪尔私人有限公司 细胞扩增方法和治疗组合物
EP3381458B1 (en) * 2015-11-24 2023-06-07 Rohto Pharmaceutical Co., Ltd. Therapeutic agent for liver disease containing stromal cells derived from adipose tissue and method for producing the same
WO2018002930A1 (en) 2016-06-30 2018-01-04 Stem Cell Medicine Ltd. Treatment of inflammatory bowel disease with long acting glatiramer and adipose-derived stem cells
EP3624816A4 (en) 2017-05-15 2021-02-24 Stem Cell Medicine Ltd. TREATMENT OF MULTIPLE SCLEROSIS WITH STEM CELLS DERIVED FROM ADIPOUS TISSUE
EP3624815A4 (en) 2017-05-15 2021-01-20 Stem Cell Medicine Ltd. TREATMENT OF MULTIPLE SCLEROSIS WITH LONG-ACTING GLATIRAMER AND ADAPTIVE STEM CELLS
US11406668B2 (en) * 2017-10-02 2022-08-09 Hirotaro FUKUOKA Pharmaceutical composition for use in improving quality of scalp or skin, wound healing, or improving quality of hair
CA3103043A1 (en) * 2018-06-15 2019-12-19 Luis Marinas Pardo Pharmaceutical composition for dermatology and uses thereof
JP7465506B2 (ja) * 2018-08-14 2024-04-11 国立研究開発法人国立国際医療研究センター 褐色脂肪細胞上清、その調製法、及び、使用
JP7429032B2 (ja) * 2019-12-24 2024-02-07 学校法人順天堂 間質性肺炎モデル非ヒト動物の作製方法
JP6826744B1 (ja) * 2020-07-17 2021-02-10 医療法人Yanaga CLinic 成熟脂肪細胞含有組成物の製造方法
CN114452303B (zh) * 2020-11-10 2025-05-30 上海萨美细胞技术有限公司 无细胞脂肪提取液对关节炎的治疗用途
IT202100003062A1 (it) * 2021-02-11 2022-08-11 Gaia Margiotta "processo di crioconservazione di tessuto adiposo"
JP7057006B1 (ja) * 2021-04-12 2022-04-19 医療法人社団サカイクリニック62 歯周組織用製剤及びそれを含むキット
CN115521908A (zh) * 2022-10-24 2022-12-27 潍坊天创生物科技有限公司 一种脂肪间充质干细胞的体外培养及外泌体的分离纯化方法
US12570949B2 (en) 2022-12-27 2026-03-10 AVITA Medical Americas, LLC Systems and devices for wound therapy and related methods of use
DE202023002794U1 (de) 2022-12-27 2024-07-15 AVITA Medical Americas, LLC Kassette zur Herstellung einer regenerativen epidermalen Suspension
USD1112812S1 (en) 2023-12-22 2026-02-10 AVITA Medical Americas, LLC Tissue processing cartridge
CN118105463B (zh) * 2024-02-27 2025-05-30 上海萨美细胞技术有限公司 脂肪脱细胞活性蛋白在抗阿尔兹海默症中的应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6037175A (en) 1996-03-12 2000-03-14 The University Of South Florida Method and media for enhancing cryopreservation of cells
US7078232B2 (en) * 1999-08-19 2006-07-18 Artecel, Inc. Adipose tissue-derived adult stem or stromal cells for the repair of articular cartilage fractures and uses thereof
US20030054331A1 (en) 2001-09-14 2003-03-20 Stemsource, Inc. Preservation of non embryonic cells from non hematopoietic tissues
JP2005508393A (ja) * 2001-11-09 2005-03-31 アーテセル・サイエンシズ・インコーポレーテツド 胚および成人幹細胞をサポートするための間質細胞の使用の方法および組成物
KR100930139B1 (ko) * 2001-12-07 2009-12-07 사이토리 테라퓨틱스, 인크. 처리된 리포애스퍼레이트 세포로 환자를 치료하기 위한시스템 및 방법
JP2007508018A (ja) * 2003-10-08 2007-04-05 べト−ステム インコーポレイテッド 新規の幹細胞組成物の調製法および使用法、ならびにこの組成物を含有するキット
US8715733B2 (en) * 2004-07-23 2014-05-06 DePuy Synthes Products, LLC Enhanced adipose tissue
WO2008018450A1 (en) * 2006-08-08 2008-02-14 National University Corporation Nagoya University Cell preparation containing multipotential stem cells originating in fat tissue
JP2010505849A (ja) 2006-10-06 2010-02-25 ユニバーシティ オブ バージニア パテント ファウンデーション 糖尿病性創傷治癒に有用な方法および組成物
WO2009115581A2 (en) * 2008-03-19 2009-09-24 Cryo-Save Ag Improved cryopreservation of adipose tissue for the isolation of mesenchymal stem cells
WO2009152084A2 (en) 2008-06-11 2009-12-17 Cell4Vet Llc Adipose tissue-derived stem cells for veterinary use
AU2009201915C1 (en) 2008-08-22 2015-02-26 Regeneus Ltd Therapeutic methods
DK2425844T3 (da) * 2009-04-28 2014-06-16 Anterogen Co Ltd Autolog og allogen stromastamcellesammensætning, der stammer fra fedtvæv, til behandling af fistler
WO2011047345A2 (en) * 2009-10-15 2011-04-21 Tai June Yoo Methods of treating diseases of conditions using mesenchymal stem cells
EP3156060B1 (en) * 2011-03-15 2019-11-06 Cell Ideas Pty Ltd. Pharmaceutical compositions and topical use thereof
EP2744892B1 (en) * 2011-09-23 2019-03-20 Cell Ideas Pty Ltd. Therapeutics using adipose cells and cell secretions

Similar Documents

Publication Publication Date Title
JP2014527821A5 (https=)
ES2880084T3 (es) Terapias que usan células adiposas y secreciones celulares
Eom et al. Mesenchymal stem cell therapy for cirrhosis: present and future perspectives
EA201490512A1 (ru) Композиции, содержащие культивируемую в анаэробных условиях микробиоту кишечника человека
EP3419635B1 (en) Pharmaceutical or veterinary cell compositions comprising mesenchymal stromal cells (mscs) and dimethyl sulfoxide (dmso)
BR112013004917A2 (pt) terapias de células tronco alogênicas sistêmicas para tratamento de doenças em animais.
AR093217A1 (es) Anticuerpos antagonistas mejorados contra factor-8 de crecimiento y diferenciacion y usos de los mismos
Mansilla et al. Could metabolic syndrome, lipodystrophy, and aging be mesenchymal stem cell exhaustion syndromes?
WO2012065027A3 (en) Compositions, kits and methods for treatment of cardiovascular, immunological, and inflammatory diseases
WO2010082787A3 (ko) 연골줄기세포를 유효성분으로 포함하는 골질환 치료용 또는 항염증용 약제학적 조성물
PH12013502529A1 (en) Freeze-dried formulations of fgf-18
KR20140040696A (ko) 간엽줄기세포 및 면역조절 t 세포를 유효성분으로 포함하는 면역질환의 예방 또는 치료용 세포치료제 조성물
HK1252778A1 (zh) 细胞扩增方法和治疗组合物
Huang et al. NKT cells mediate the recruitment of neutrophils by stimulating epithelial chemokine secretion during colitis
Chen et al. Current state of heart failure treatment: are mesenchymal stem cells and their exosomes a future therapy?
Gherghel et al. Osteoarthritis—the role of mesenchymal stem cells in cartilage regeneration
JP2012507997A5 (https=)
TW201613621A (en) Composition for promoting growth of dermal papilla cells, pharmaceutical composition, and preparation method thereof
WO2009015279A3 (en) Agents and methods for inhibition of airway hyperresponsiveness
Tremolada Mesenchymal stem cells and regenerative medicine: how Lipogems technology make them easy, safe and more effective to use
Szydlak Cellular architects of healing: mesenchymal stem cell-based strategies for fibrosis
Kim et al. Adipose-derived Stem Cell-Based Immunomodulatory Therapy in a Translational Porcine Limb Transplant Model
CN104488827A (zh) 一种利用鸡粪养殖蚯蚓的方法
Al-Agelea et al. THE POTENTIALITY OF MESENCHYMAL STEM CELLS IN THE REHABILITATION OF EQUINE TENDONITIS
CN102988884B (zh) 一种治疗癫痫的中药组合物